Philippe Van Hootegem

Statistics

Publications

Citations

2.2K

H-Index

Active since

1985

Affiliations

Imelda Hospital(Current)

Philippe Van Hootegem is an author at Imelda Hospital specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and gastrointestinal inflammation.

ORCID

Publications per year

1985–2023

Publications

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Geert D’Haens, Filip Baert, Gert Van Assche et al. · The Lancet · 2008 · 1.2K citations

Medicine, Clinical Sciences, Immunology +12

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Geert D’Haens, Séverine Vermeire, Guy Lambrecht et al. · Gastroenterology · 2018 · 299 citations · Full text

Veterinary Medicine, Clinical Sciences, Pharmacotherapy +12

Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

Martine De Vos, Édouard Louis, Jørgen Jahnsen et al. · Inflammatory Bowel Diseases · 2013 · 204 citations

Medicine, Clinical Sciences, Internal Medicine +14

Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn’s Disease Who Failed Biologic Therapies: A National Cohort Study

Claire Liefferinckx, Bram Verstockt, Ann Gils et al. · Journal of Crohn s and Colitis · 2019 · 120 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial

Édouard Louis, Matthieu Resche‐Rigon, David Laharie et al. · The Lancet. Gastroenterology & hepatology · 2023 · 108 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

1–5 of 13